Minimal Residual Disease (MRD) Testing Market – Refining Cancer Treatment Monitoring
Market Overview Oncology care continues to advance toward more sensitive methods of tracking treatment response beyond conventional imaging. The Minimal Residual Disease Mrd Testing Market is expanding as clinicians use highly sensitive molecular assays to detect trace cancer cells remaining after treatment, guiding decisions on therapy continuation or de-escalation. Hematology-oncology centers...
0 Comments 0 Shares 193 Views 0 Reviews